Literature DB >> 6896428

Comparison of serum 1,25-dihydroxycholecalciferol concentrations in rheumatoid arthritis and osteoarthrosis.

H A Bird, V Wright, U Hennes, E Theiss.   

Abstract

We have previously compared 25-hydroxycholecalciferol levels in the serum of patients with osteoarthrosis and rheumatoid arthritis, finding no significant difference between the circulating levels of this hormone. We have now estimated 1,25-dihydroxycholecalciferol levels on stored sera from the same groups of patients and found no significant difference in the levels of this hormone between the 2 groups. The osteopenia that distinguishes rheumatoid arthritis from osteoarthrosis is not the result of altered levels of systemic 25OHD3 or of 1,25(OH)2D3. Local factors may be more important in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896428      PMCID: PMC1000922          DOI: 10.1136/ard.41.3.257

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  3 in total

1.  Sunlight, vitamin D, and osteomalacia in the elderly.

Authors:  H M Hodkinson; P Round; B R Stanton; C Morgan
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

2.  An improved competitive protein binding assay for 1,25-dihydroxyvitamin D.

Authors:  J P Mallon; J G Hamilton; C Nauss-Karol; R J Karol; C J Ashley; D S Matuszewski; C A Tratnyek; G F Bryce; O N Miller
Journal:  Arch Biochem Biophys       Date:  1980-04-15       Impact factor: 4.013

3.  Comparison of serum 25-OH vitamin D concentrations in rheumatoid arthritis and osteoarthrosis.

Authors:  H A Bird; M Peacock; J H Storer; V Wright
Journal:  Br Med J       Date:  1980-06-14
  3 in total
  11 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

Review 2.  Bone metabolism in patients with rheumatoid arthritis.

Authors:  J W Bijlsma
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

3.  Serum osteocalcin concentrations in patients with rheumatoid arthritis.

Authors:  P Pietschmann; K P Machold; W Wolosczuk; J S Smolen
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

4.  Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis.

Authors:  M E Hayes; D Bayley; P Still; J Palit; J Denton; A J Freemont; R G Cooper; E B Mawer
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  Serum concentration of vitamin D metabolites in rheumatoid arthritis.

Authors:  O S Als; B Riis; C Christiansen
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

6.  A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.

Authors:  H A Bird; L Burkinshaw; D Pearson; P J Atkinson; P A Leatham; J Hill; A Raven; V Wright
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

7.  Osteopenia in rheumatoid arthritis: a biochemical, hormonal and histomorphometric study.

Authors:  H Rico; E R Hernandez; F Gomez-Castresana; M Yague; J A Cabranes; R Valor
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

8.  Calcium absorption in rheumatoid arthritis.

Authors:  P N Sambrook; G Abeyasekera; B M Ansell; S Foster; J M Gumpel; P A Hill; J Reeve; J C Stevenson
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

9.  Incidence of metabolic bone disease in rheumatoid arthritis and osteoarthritis.

Authors:  K C Ng; P A Revell; M Beer; B J Boucher; R D Cohen; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  Vitamin D metabolites in synovial fluid.

Authors:  A Fairney; A M Straffen; C May; M H Seifert
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.